A preclinical study reports a platform for the generation of dendritic cell-derived nanovesicles with enhanced immunostimulatory function, which demonstrate promising antitumoural activity in mouse models and might overcome some of the shortcomings of early-generation dendritic cell nanovaccines.
Camille Sophie Brès, Anton Stroganov, Ozan Yakar, Marco Clementi, Christian André Clément Lafforgue, Anamika Nair Karunakaran
, ,
Corentin Jean Dominique Fivet, Pierluigi D'Acunto, Jonas Warmuth